Could a single daily pill deliver Parkinson’s medication?

News

Author: Simge Eva DoganPublished: 1 October 2020

Prep: Cook: Serves:

NTU Assoc Prof Joachim Loo and LiberaTx COO Shashi Kesavapany holding their new drug microcapules in their hands

Scientists at Nanyang Technological University, Singapore, have developed a new pill that could be used to slowly deliver medication over a 24-hour period to people living with Parkinson’s disease.

They hope that delivering Parkinson’s medication in this way could help manage symptoms which can occur when people experience ‘off’ periods between taking medications. A team at the university’s startup LiberaTx is now commercialising the technology and planning clinical trials to test the efficacy of the pill.

Joachim Loo (pictured left), associate professor at the university and founder of LiberaTx, said: “We hope that […] reducing dosage to just once-a-day would greatly improve patient compliance, lower the pill burden of these patients, while alleviating the ‘off’ periods that these patients experience. Achieving this would greatly improve quality of life for the patient.”

If the pill is proven successful for treating Parkinson’s disease, it may also be used for treating other conditions that require taking multiple drugs daily.

Lead image credit: NTU Singapore

Read more about the new pill for delivering Parkinson’s medication here.

For more information on the latest Parkinson’s research please visit the EPDA website.

Has Covid-19 impacted access to Parkinson’s medication?

Last Month

Next Month

Go Back

Share this story

Comments

PD in Practice

Tips and tricks: how Parkinson’s patients can discover their own coping strategies

Bouncing a ball or riding a bike could help your symptoms

Powerful partnership promotes Parkinson’s rehab in Jerusalem

A partnership helped to expand exercise and therapy sessions in Jerusalem

Copenhagen carnival: campaigners and cyclists join forces for Unity Walk

Copenhagen’s streets to be overrun with Parkinson’s campaigners

Weight, sleep and depression linked to risk of cognitive problems in Parkinson’s

Researchers at the University of Pennsylvania, US, have found that people with early Parkinson’s disease are at higher risk of developing cognitive impairments if they are overweight, have disruptive sleep behaviours or experience symptoms of depression. Evaluating data from 405 people, the researchers used statistical analysis to identify relationships between certain characteristics and changes in patient cognition over time. Their findings suggest that factors such as high body mass index (BMI) or excessive sleepiness are associated with a faster rate of cognitive decline in Parkinson’s disease. The researchers wrote: “Despite its common and devastating occurrence, treatment of [cognitive impairments] in [Parkinson’s disease] is limited and no medications slow its onset or progression. However, identification of treatable or modifiable comorbidities that affect the rate of progression of [cognitive impairments] in [Parkinson’s disease] could provide opportunities for early intervention and improved prognosis.”

Gene screening technique could offer insights on Parkinson’s disease

Researchers from the Massachusetts Institute of Technology (MIT), US, will investigate genes that could protect cells in the brain against Parkinson’s disease. An award from US non-profit G Harold and Leila Y Mathers Foundation will allow scientists to use a mouse model screening technique to find out more about the condition. Individually deleting each of the 22,000 genes present in mice neurons will help identify which genes are linked to neuron survival – and offer insights that could lead to new treatments for the condition. Dr Myriam Heiman, an Associate Professor at MIT, said: “There is currently no molecular explanation for the brain cell loss seen in Parkinson’s disease or a cure for this devastating disease. I’m extremely grateful for this generous support and recognition of our work from the Mathers Foundation, and hope that our study will elucidate new therapeutic targets for the treatment and even prevention of Parkinson’s…

Can equine-assisted therapy benefit people with Parkinson’s disease?

Researchers from Texas Woman’s University, US, are investigating how equine-assisted therapy – which involves working with horses to promote wellbeing – can benefit people with Parkinson’s disease. As part of the five-month study, funded by the non-profit Human Animal Bond Research Institute, 30 men with Parkinson’s disease will be randomly assigned to participate in equine-assisted therapy or simulated horseback riding. The participants’ motor performance, balance, gait and symptoms related to Parkinson’s disease will be assessed before, during and after the therapy. Rhett Rigby, principal investigator of the study, said: “There is currently no known study that utilises equine-assisted therapy as an intervention treatment for those with Parkinson’s disease. Our research could have a significant impact on an understudied population and help contribute to the existing literature on human-animal interaction.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Could a single daily pill deliver Parkinson’s medication?

News

Author: Simge Eva DoganPublished: 1 October 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

PD in Practice

Tips and tricks: how Parkinson’s patients can discover their own coping strategies

In my country

Powerful partnership promotes Parkinson’s rehab in Jerusalem

Europe

Copenhagen carnival: campaigners and cyclists join forces for Unity Walk

Weight, sleep and depression linked to risk of cognitive problems in Parkinson’s

Gene screening technique could offer insights on Parkinson’s disease

Can equine-assisted therapy benefit people with Parkinson’s disease?

{title}

Subscribe

Could a single daily pill deliver Parkinson’s medication?

News

Author: Simge Eva DoganPublished: 1 October 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

PD in Practice

Tips and tricks: how Parkinson’s patients can discover their own coping strategies

In my country

Powerful partnership promotes Parkinson’s rehab in Jerusalem

Europe

Copenhagen carnival: campaigners and cyclists join forces for Unity Walk

Weight, sleep and depression linked to risk of cognitive problems in Parkinson’s

Gene screening technique could offer insights on Parkinson’s disease

Can equine-assisted therapy benefit people with Parkinson’s disease?

{title}

Subscribe

Sign in